Vaccinia Vaccine (ACAM2000) for the Production of Vaccinia Immune Globulin Intravenous.

Trial Profile

Vaccinia Vaccine (ACAM2000) for the Production of Vaccinia Immune Globulin Intravenous.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Feb 2012

At a glance

  • Drugs ACAM 2000 (Primary)
  • Indications Smallpox
  • Focus Pharmacodynamics
  • Acronyms VIGIV
  • Most Recent Events

    • 29 Feb 2012 Actual patient number 25 added as reported by ClinicalTrials.gov.
    • 29 Feb 2012 Actual end date Feb 2012 added as reported by ClinicalTrials.gov.
    • 29 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top